WASHINGTON — He’s one of the richest men in the world. He’s sought to eradicate malaria, pledged $10 billion to help fund childhood vaccinations, and poured another $3 billion into fighting HIV. But Bill Gates has been far more restrained in bankrolling research into Alzheimer’s disease.
One of the first investments made by the billionaire’s Gates Ventures was in the Dementia Discovery Fund, which invests in novel science. But, all told, Gates’ Alzheimer’s investments only total roughly $100 million, which even Gates’ chief science adviser, Niranjan Bose, acknowledges is a “drop in the bucket.”